tiprankstipranks
Parnell Pharmaceuticals (PARNF)
OTHER OTC:PARNF
US Market

Parnell Pharmaceuticals (PARNF) Financial Statements

16 Followers

Parnell Pharmaceuticals Financial Overview

Parnell Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Parnell Pharmaceuticals is scheduled to report earnings on December 23, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 16Sep 16Jun 16Dec 15Sep 15
Income Statement-
Total RevenueAU$ 6.42MAU$ 4.55M-AU$ 4.05MAU$ 6.17M
Gross ProfitAU$ 3.78MAU$ 1.86M-AU$ 1.54MAU$ 4.08M
EBITAU$ -1.74MAU$ -5.54M-AU$ -7.97MAU$ -1.85M
EBITDAAU$ -1.74MAU$ -5.54M-AU$ -7.97MAU$ -1.85M
Net Income Common StockholdersAU$ -3.11MAU$ -6.11M-AU$ -8.32MAU$ -2.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 7.12MAU$ 2.07MAU$ 4.10MAU$ 5.67MAU$ 0.00
Total AssetsAU$ 47.58MAU$ 39.05MAU$ 46.66MAU$ 46.21M-
Total DebtAU$ 29.84MAU$ 16.94MAU$ 20.20MAU$ 17.48MAU$ 0.00
Net DebtAU$ 22.73MAU$ 14.87MAU$ 16.10MAU$ 11.81MAU$ 0.00
Total LiabilitiesAU$ 39.51MAU$ 26.88MAU$ 29.85MAU$ 25.95M-
Stockholders EquityAU$ 8.06MAU$ 12.17MAU$ 16.81MAU$ 20.25MAU$ 0.00
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Parnell Pharmaceuticals Earnings and Revenue History

Parnell Pharmaceuticals Debt to Assets

Parnell Pharmaceuticals Cash Flow

Parnell Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis